Search | Pikumil

Sayantan Roy added blog Other
2026-07-01 11:31:16 -

Global Polypeptide Anti-aging Agent Market to Reach USD 8.12 Billion by 2032, Growing at 7.6% CAGR
Global Polypeptide Anti-aging Agent market size was valued at USD 4.51 billion in 2024. The market is projected to grow from USD 4.87 billion in 2025 to USD 8.12 billion by 2032, exhibiting a CAGR of 7.6% during the forecast period. Polypeptide anti-aging agents are short chains of amino acids that serve as signaling molecules to stimulate collagen production and other skin repair processes....

0 Comments 0 Shares 242 Views 0 Reviews

Please log in to like, share and comment!
Priti Mrfr added blog Health
2026-08-19 07:22:57 -

Gastric Inhibitory Polypeptide Receptor Market – Metabolic Innovation Reshaping Endocrinology Therapeutics
Market Overview The gastric inhibitory polypeptide receptor market is accelerating as pharmaceutical developers target incretin pathways to treat complex metabolic disorders, including type 2 diabetes and obesity. Institutions and research laboratories are shifting from single-hormone therapies to multi-agonist receptor molecules that simultaneously activate GIP and GLP-1 pathways for superior...

0 Comments 0 Shares 108 Views 0 Reviews

Please log in to like, share and comment!
Anuj Mrfr added blog Wellness
2026-08-20 06:19:53 -

Islet Amyloid Polypeptide Market – Innovative Therapies for Diabetes and Metabolic Disorders
The Islet Amyloid Polypeptide (IAPP) market is a specialized segment of the pharmaceutical industry, providing innovative therapies for diabetes and metabolic disorders. IAPP is a peptide hormone co-secreted with insulin by pancreatic beta cells, playing a crucial role in glucose regulation and appetite control. With rising prevalence of type 2 diabetes, increasing research funding, and...

0 Comments 0 Shares 167 Views 0 Reviews

Please log in to like, share and comment!
Prashil Sawale added blog Food
2026-05-25 14:27:02 -

Polypeptide Market Expected to Maintain a Robust and Progressive CAGR Fuelled by the Surge in Chronic Disease Therapies
The global polypeptide market is entering an era of accelerated capital investment, driven by the expanding therapeutic applications of custom and bioactive polypeptide sequences across metabolic, oncology, and cardiovascular fields. Global biopharmaceutical innovators, contract development and manufacturing organizations (CDMOs), and macromolecular clinical research hubs are aggressively...

0 Comments 0 Shares 179 Views 0 Reviews

Please log in to like, share and comment!